- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Submit a Manuscript
- Subscription Information
- Table of Contents
Case Reports in Urology
Volume 2013 (2013), Article ID 675059, 4 pages
Inflammatory Myofibroblastic Bladder Tumor in a Patient with Wolf-Hirschhorn Syndrome
1Pediatric Surgery, Second University of Naples, Largo Madonna delle Grazie, 80138 Naples, Italy
2Pediatric Oncology Service, Pediatric Department, Second University of Naples, Italy
3Pathology Department, Federico II University of Naples, Italy
Received 12 June 2013; Accepted 10 July 2013
Academic Editors: S.-S. Chen, A. Goel, and M. Sheikh
Copyright © 2013 Antonio Marte et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- L. Cheng, S. R. Foster, G. T. MacLennan, A. Lopez-Beltran, S. Zhang, and R. Montironi, “Inflammatory myofibroblastic tumors of the genitourinary tract-single entity or continuum?” The Journal of Urology, vol. 180, no. 4, pp. 1235–1240, 2008.
- P. Yimyaem, S. Saranrittichai, P. Sinawat, and T. Dhiensiri, “Inflammatory myofibroblastic tumor of the small intestine: a case report of a 2 month-old infant,” Journal of the Medical Association of Thailand, vol. 92, no. 1, pp. 114–119, 2009.
- D. Nonaka, R. Birbe, and J. Rosai, “So-called inflammatory myofibroblastic tumour: a proliferative lesion of fibroblastic reticulum cells?” Histopathology, vol. 46, no. 6, pp. 604–613, 2005.
- L. D. Narla, B. Newman, S. S. Spottswood, S. Narla, and R. Kolli, “Inflammatory Pseudotumor,” Radiographics, vol. 23, no. 3, pp. 719–729, 2003.
- C. D. M. Fletcher and F. Mertens, World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone, IARC Press, Lyon, France, 2002.
- P. Dall'Igna, G. Cecchetto, M. Guglielmi, and R. Alaggio, “Clinical and pathologic considerations in a case of inflammatory myofibroblastic tumor of the spleen,” Pediatric Surgery International, vol. 20, no. 11-12, pp. 875–877, 2004.
- I. Gómez García, R. Molina Burgos, E. Fernández Fernández, et al., “Myofibroblastic tumor of bladder,” Actas Urológicas Españolas, vol. 29, no. 6, pp. 611–614, 2005.
- L. R. Harik, C. Merino, J. M. Coindre, M. B. Amin, F. Pedeutour, and S. W. Weiss, “Pseudosarcomatous myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases,” American Journal of Surgical Pathology, vol. 30, no. 7, pp. 787–794, 2006.
- E. A. Montgomery, D. D. Shuster, A. L. Burkart et al., “Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma,” American Journal of Surgical Pathology, vol. 30, no. 12, pp. 1502–1512, 2006.
- G. Pettinato, J. C. Manivel, N. de Rosa, and L. P. Dehner, “Inflammatory myofibroblastic tumor (plasma cell granuloma). Clinicopathologic study of 20 cases with immunohistochemical and ultrastructural observations,” American Journal of Clinical Pathology, vol. 94, no. 5, pp. 538–546, 1990.
- C. M. Coffin, A. Patel, S. Perkins, K. S. J. Elenitoba-Johnson, E. Perlman, and C. A. Griffin, “ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor,” Modern Pathology, vol. 14, no. 6, pp. 569–576, 2001.
- W. R. Sukov, J. C. Cheville, A. W. Carlson et al., “Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder,” Modern Pathology, vol. 20, no. 5, pp. 592–603, 2007.
- N. L. Shannon, E. L. Maltby, A. S. Rigby, and O. W. J. Quarrell, “An epidemiological study of Wolf-Hirschhorn syndrome: life expectancy and cause of mortality,” Journal of Medical Genetics, vol. 38, no. 10, pp. 674–679, 2001.
- I. W. Lurie, G. I. Lazjuk, Y. I. Ussova, et al., “The Wolf-Hirschhorn syndrome. I. Genetics,” Clinical Genetics, vol. 17, no. 6, pp. 375–384, 1980.
- K. Hirschhorn, H. L. Cooper, and I. L. Firschein, “Deletion of short arms of chromosome 4-5 in a child with defects of midline fusion,” Human Genetics, vol. 1, no. 5, pp. 479–482, 1965.
- S. Pardo, N. Blitman, B. Han, N. Cohen, L. Edelmann, and K. Hirschhorn, “Multiple hemangiomas in a patient with a t(3q;4p) translocation: an infrequent association with Wolf-Hirschhorn syndrome,” American Journal of Medical Genetics A, vol. 146, no. 2, pp. 219–224, 2008.
- B. Batton, A. Amanullah, C. Main, D. Fivenson, and S. Jamil, “Cutaneous T-cell lymphoma in a 21-year-old male with Wolf-Hirschhorn syndrome,” American Journal of Medical Genetics A, vol. 127, no. 1, pp. 81–85, 2004.
- A. Sharathkumar, M. Kirby, M. Freedman et al., “Malignant hematological disorders in children with Wolf-Hirschhorn syndrome,” American Journal of Medical Genetics A, vol. 119, no. 2, pp. 194–199, 2003.
- C. Basilico and D. Moscatelli, “The FGF family of growth factors and oncogenes,” Advances in Cancer Research, vol. 59, pp. 115–165, 1992.